Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
Amylin Pharmaceuticals, 10/20/09
Amylin Pharmaceuticals, Inc. announced that new data from its obesity program will be presented at Obesity 2009, the 27th Annual Scientific Meeting of The Obesity Society, to be held in Washington, D.C. October. Phase 2 data from the pramlintide/metreleptin combination treatment clinical program will be the subject of a late–breaking oral presentation. Obesity 2009 is one of the largest scientific conferences in the field of obesity.
Today in Conferences/Meetings...keeping you current
Receive free subspecialty "5-minute updates" via email
Inspire Announces Webcast of Presentation at Piper Jaffray Health Care Conference
Inspire, 11/30/09
Medtronic CEO William Hawkins to Speak at 21st Annual Piper Jaffray Healthcare Conference
Medtronic, 11/30/09
Genmab to present at 21st annual piper jaffray health care conference
Genmab, 11/30/09
Sponsor
Article Search
Sponsor


See Latest Articles


